|
Beckley Foundation Global Drug Policy Seminar 2005
House of Lords, Westminster Palace, London
This annual seminar brought together top scientists and academics, senior politicians, policy analysts and other experts in order to debate this most difficult area of social policy.
Partly held, as last year, in the House of Lords, Palace of Westminster, London, the event incorporated four interlinked sessions:
1) The Beckley Foundation Global Drug Policy Seminar 2005, which evaluated the latest evidence and challenges in national and international drug policy and the effects of policy on supply, crime and health. The afternoon session examined the impact of international drug controlled systems on scientific and medical research.
2) The Beckley/Foresight Seminar on Future Policy Challenges, jointly hosted with Foresight, a UK Government think-tank, reviewed the Foresight Report on how best to manage the use of psychoactive substances for the good of the individual, the community and society over the next 20 years.
3) The Symposium of the International Network of Drug Policy Analysis, in which internationally acclaimed drug policy analysts met to give academic talks and discuss future collaboration.
4)The Meeting of the International Drug Policy Consortium , at which NGOs from around the world concerned with drug policy and related problems, met to discuss the future.
At this three day event, participants, who came by invitation only, were able to debate, in a respectful and confidential atmosphere. The events followed Chatham House rules, but there will be a Proceedings Document produced, which will summarize the discussions of the two main seminars.
To download the whole Proceedings document: Global Drug Policy Seminar 2005, please click here.
DAY ONE:
THE BECKLEY FOUNDATION GLOBAL DRUG POLICY SEMINAR 2005 - Monday 21st November, 2005
Preface
Executive Summary
Introduction by Amanda, Lady Neidpath
MORNING SESSION: REDUCTION OF DRUG-RELATED PROBLEMS
Dr. Marcus Roberts and Prof. Francisco Thoumi
Law Enforcement and Supply Reduction
Alex Stevens and Prof. Mark Kleiman
Reducing Drug-Related Crime: An Overview of the Global Evidence
Prof. Gerry Stimson and Dr. Anindya Chatterjee
Reducing Drug-Related Harm to Health
AFTERNOON SESSION:
IMPACT OF INTERNATIONAL DRUG CONTROL SYSTEMS
ON SCIENTIFIC AND MEDICAL RESEARCH
Chair Prof. Colin Blakemore
Chair's Introduction
Prof. Leslie Iversen The Medical Potential of Cannabis
Rob Kampia The Effects of Medical Regulation of Cannabis in the USA
Prof. David Nichols The Scientific and Therapeutic Potential of Psychedelics
Dr. John Marsden Cognitive Enhancers – Blurring the Boundaries
DAY TWO :
THE BECKLEY/FORESIGHT SEMINAR ON FUTURE POLICY CHALLENGES - Tuesday 22nd November 2005
Executive Summary
Introduction by Amanda, Lady Neidpath
Dr. Andrew Jackson
Introduction and Strategic Challenges
Prof. David Nutt
The Science Behind the Future of Recreational Drugs
HARM REDUCTION AND THE WIDER SOCIAL CONTEXT
Prof. Gerry Stimson and discussant Prof Peter Reuter Harm Reduction and the Wider Social Context: Social, Ethical and Regulatory Implications
REGULATION AND UNDERLYING REASONS FOR DRUG USE
Prof. Robert MacCoun Why do People Use Drugs?
Prof. Mark Kleiman
Is evidenced-based dugs policy possible?
Prof. Trevor Robbins and discussant Prof. Barbara Sahakian
Blurring the Boundaries – the Future of Cognitive Enhancers
ETHICAL DILEMMAS
Dr. Harald Schmidt and discussant Prof . Alastair Campbell
Rights and Responsibilities
CLOSING DISCUSSION
Prof. Colin Blakemore and Prof. Charles Schuster
EPILOGUE
Prof. Charles Schuster Drugs and the Future
DAY THREE:
DEVELOPING TWO ORGANISATIONS FOUNDED BY THE BECKLEY FOUNDATION:
International Society for the Study of Drug Policy (ISSDP)
The International Drug Policy Consortium (IDPC)
APPENDICES
|